Cargando…

COVID-19 infection in patients with mast cell disorders including mastocytosis does not impact mast cell activation symptoms

Detalles Bibliográficos
Autores principales:	Giannetti, Matthew P., Weller, Emily, Alvarez-Twose, Iván, Torrado, Inés, Bonadonna, Patrizia, Zanotti, Roberta, Dwyer, Daniel F., Foer, Dinah, Akin, Cem, Hartmann, Karin, Rama, Tiago Azenha, Sperr, Wolfgang R., Valent, Peter, Teodosio, Cristina, Orfao, Alberto, Castells, Mariana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Academy of Allergy, Asthma & Immunology 2021
Materias:	Clinical Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899934/ https://www.ncbi.nlm.nih.gov/pubmed/33631409 http://dx.doi.org/10.1016/j.jaip.2021.02.023

Ejemplares similares

COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM)
por: Bonadonna, Patrizia, et al.
Publicado: (2021)

mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis
por: Rama, Tiago Azenha, et al.
Publicado: (2021)

Mastocytosis presenting with mast cell‐mediator release‐associated symptoms elicited by cyclo oxygenase inhibitors: prevalence, clinical, and laboratory features
por: Rama, Tiago Azenha, et al.
Publicado: (2022)

Bone Marrow Mast Cell Antibody-Targetable Cell Surface Protein Expression Profiles in Systemic Mastocytosis
por: Dasilva-Freire, Noelia, et al.
Publicado: (2019)

Safety of COVID-19 vaccination in patients with mastocytosis and monoclonal mast cell activation syndrome
por: Kaakati, Rayan, et al.
Publicado: (2021)

Epigenetic Changes in Neoplastic Mast Cells and Potential Impact in Mastocytosis
por: Reszka, Edyta, et al.
Publicado: (2021)

Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: Expert opinions
por: Valent, Peter, et al.
Publicado: (2020)

Advances in the understanding and clinical management of mastocytosis and clonal mast cell activation syndromes
por: González-de-Olano, David, et al.
Publicado: (2016)

Updated Diagnostic Criteria and Classification of Mast Cell Disorders: A Consensus Proposal
por: Valent, Peter, et al.
Publicado: (2021)

Role of Mast Cells in the Pathogenesis of Pruritus in Mastocytosis
por: KWIATKOWSKA, Dominika, et al.
Publicado: (2021)

Multidisciplinary Challenges in Mastocytosis and How to Address with Personalized Medicine Approaches
por: Valent, Peter, et al.
Publicado: (2019)

Mastocytosis and Mast Cell Activation Disorders: Clearing the Air
por: Jackson, Clayton Webster, et al.
Publicado: (2021)

Diagnosis, Classification and Management of Mast Cell Activation Syndromes (MCAS) in the Era of Personalized Medicine
por: Valent, Peter, et al.
Publicado: (2020)

Mast Cell Activation Syndromes: Collegium Internationale Allergologicum Update 2022
por: Valent, Peter, et al.
Publicado: (2022)

P1017: HARBOR: A PHASE 2/3 STUDY OF BLU-263 IN PATIENTS WITH INDOLENT SYSTEMIC MASTOCYTOSIS AND MONOCLONAL MAST CELL ACTIVATION SYNDROME
por: Castells, M., et al.
Publicado: (2022)

Presumed mast cell choroidal infiltrate in aggressive systemic mastocytosis
por: Tran, Tu M., et al.
Publicado: (2020)

A Puzzling Mast Cell Trilogy: Anaphylaxis, MCAS, and Mastocytosis
por: Gülen, Theo
Publicado: (2023)

Antibody-Based and Cell Therapies for Advanced Mastocytosis: Established and Novel Concepts
por: Valent, Peter, et al.
Publicado: (2023)

Recent advances in mast cell clonality and anaphylaxis
por: Akin, Cem
Publicado: (2009)

Insights in Anaphylaxis and Clonal Mast Cell Disorders
por: González-de-Olano, David, et al.
Publicado: (2017)

Clinical presentation and markers of cutaneous versus systemic mastocytosis: the mastocytosis center at brigham and women's hospital in Boston
por: Kanamori, Kelly Yoshimi, et al.
Publicado: (2015)

Systemic mastocytosis presenting as cardiac tamponade with CD25(+) pericardial mast cells
por: Sukrithan, Vineeth K., et al.
Publicado: (2016)

Mast cells derived from systemic mastocytosis exhibit an increased responsiveness to hyperosmolarity
por: Lyberg, Katarina, et al.
Publicado: (2022)

COVID-19 Vaccination Is Safe among Mast Cell Disorder Patients, under Adequate Premedication
por: Rama, Tiago Azenha, et al.
Publicado: (2022)

Mast cells as a unique hematopoietic lineage and cell system: From Paul Ehrlich's visions to precision medicine concepts
por: Valent, Peter, et al.
Publicado: (2020)

Case Report: Mastocytosis: The Long Road to Diagnosis
por: Rama, Tiago Azenha, et al.
Publicado: (2021)

Bone Marrow Mastocytosis: A Diagnostic Challenge
por: Zanotti, Roberta, et al.
Publicado: (2021)

Acute Myeloid Leukemia with Occult Systemic Mastocytosis or Atypical Mast Cells Post-induction
por: Khan, Salahuddin, et al.
Publicado: (2018)

Systemic Mastocytosis and Other Entities Involving Mast Cells: A Practical Review and Update
por: El Hussein, Siba, et al.
Publicado: (2022)

A Challenge for Allergologist: Application of Allergy Diagnostic Methods in Mast Cell Disorders
por: Romantowski, Jan, et al.
Publicado: (2021)

Mastocytosis patients' cognitive dysfunctions correlate with the presence of spindle‐shaped mast cells in bone marrow
por: Spolak‐Bobryk, Natalia, et al.
Publicado: (2022)

Circulating promastocytes and atypical mast cells in systemic mastocytosis associated with acute myelogenous leukaemia transformation
por: Altohami, Mohammed O. A., et al.
Publicado: (2021)

Comprehensive Analysis of Acquired Genetic Variants and Their Prognostic Impact in Systemic Mastocytosis
por: González-López, Oscar, et al.
Publicado: (2022)

Systemic Mastocytosis: Multidisciplinary Approach
por: Zanotti, Roberta, et al.
Publicado: (2021)

Preclinical human models and emerging therapeutics for advanced systemic mastocytosis
por: Arock, Michel, et al.
Publicado: (2018)

Molecular Background, Clinical Features and Management of Pediatric Mastocytosis: Status 2021
por: Lange, Magdalena, et al.
Publicado: (2021)

MARS: Mutation-Adjusted Risk Score for Advanced Systemic Mastocytosis
por: Jawhar, Mohamad, et al.
Publicado: (2019)

Mast Cell Activation Disorders
por: Giannetti, Arianna, et al.
Publicado: (2021)

Hodgkin’s lymphoma is a rare form of clonal haematological non-mast cell disease in systemic mastocytosis
por: Gasljevic, Gorana, et al.
Publicado: (2015)

Evolution of myelodisplasic syndrome with ring sideroblasts (MDS-RS) to systemic mastocytosis and aleukemic mast cell leukemia
por: Costa, Larissa da, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fsc5mjjaov1kekbtq7s9bi29et